Tag:

Clinical Trials

New Cancer Vaccine Research Shows Promise New Cancer Vaccine Research Shows Promise
New Cancer Vaccine Research Shows Promise A small but striking study is giving cancer researchers another reason to closely watch a new kind of treatment. An experimental personalized mRNA vaccine showed lasting results in some patients with pancreatic cancer, Memorial Sloan Kettering Cancer Center in New York City reported. The phase 1 trial involved 16 patients who received the vaccine after pancreatic cancer surgery, along with chemotherapy and an immunotherapy drug. The vaccine, called autogene cevumeran, was custom-made for each patient using the unique genetic changes in that person’s tumor. In eight of the 16 patients, the…
COVID-19: FDA Says It Will Limit Who Can Get Future Booster Shots COVID-19: FDA Says It Will Limit Who Can Get Future Booster Shots
Covid-19: FDA Says It Will Limit Who Can Get Future Booster Shots In a significant shift in vaccination policy, the Trump administration has revealed that approval for seasonal COVID-19 shots will be restricted to certain groups. The Food and Drug Administration (FDA) says it will continue to approve boosters for those 65 and older as well as others at higher risk of severe disease. But it will require vaccine makers to conduct major new clinical trials on their effectiveness before approving them for wider use on the broader population.  The FDA’s revised framework, published in the New England Journal of Medicine on Tuesday, May 20, stat…
CT Ranks Among Top States For Cancer Research With High Clinical Trial Access CT Ranks Among Top States For Cancer Research With High Clinical Trial Access
CT Ranks Among Top States For Cancer Research With High Clinical Trial Access Many states in the Northeast are among the country's best in the fight against cancer, with Massachusetts, New York, and Maryland ranked as leaders, a new study said. Massachusetts was ranked as the best state for cancer research, according to a SmileHub study released on Tuesday, Jan. 7. New York was just behind the Bay State in second place. The study, which assessed all 50 states based on metrics like clinical trials per capita and hospital quality, came as the U.S. saw more than 611,000 cancer-related deaths and nearly two million new cases in 2024. Massachusetts boasts the highes…